Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment

Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment

Aim:Visceral leishmaniasis (VL) is a systemic infection that spreads hematogenously and affects the reticuloendothelial system by the infection of macrophages. VL occurs commonly in children, and only rarely in adults. VL should be considered in patients with prolonged high fever, hepatosplenomegaly...

Full description

Bibliographic Details
Main Authors:	Barbaros Şahin Karagün, Özlem Özgür, İlgen Şaşmaz, Bülent Antmen, Emine Kocabaş, Emre Alhan
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-06-01
Series:	Journal of Pediatric Research
Subjects:	Leishmania visceral leishmaniasis liposomal Amphotericin B child Turkey
Online Access:	http://jpedres.org/archives/archive-detail/article-preview/visceral-leishmaniasis-in-children-in-southern-tur/27900

Similar Items

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
by: Maria Ubals, et al.
Published: (2021-09-01)

A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies
by: Arianna Dondi, et al.
Published: (2023-12-01)

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis
by: Shirzadi MR
Published: (2019-04-01)

Subclinical tumor lysis-like syndrome during treatment of visceral leishmaniasis with low-dose intermittent liposomal amphotericin B
by: Georgiadou Sarah, et al.
Published: (2012-06-01)

Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis
by: Danfeng Ren, et al.
Published: (2021-11-01)

Visceral leishmaniasis in pregnant women from Rio Grande do Norte, Brazil: A case report and literature review
by: Francielly Tertulino Cunha, et al.
Published: (2019-02-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-05-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-02-01)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
by: Guilherme S. Ramos, et al.
Published: (2022-05-01)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
by: Md Golam Hasnain, et al.
Published: (2018-12-01)

The man who petted sandflies: A rare case of visceral leishmaniasis with panhypopituitarism
by: Arjun B Hari, et al.
Published: (2024-01-01)

Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
by: Sarah P. Georgiadou, et al.
Published: (2015-05-01)

Liposomal amphotericin B and leishmaniasis: Dose and response
by: Shyam Sundar, et al.
Published: (2010-01-01)

Cytokine expression in the duodenal mucosa of patients with visceral leishmaniasis Expressão de citocinas na mucosa duodenal de pacientes com leishmaniose visceral
by: Kleber Giovanni Luz, et al.
Published: (2010-08-01)

Elucidating the role played by bone marrow in visceral leishmaniasis
by: Patricia Sampaio Tavares Veras, et al.
Published: (2023-10-01)

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
by: Frédéric Frézard, et al.
Published: (2022-12-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis
by: Santos Mácia A., et al.
Published: (2002-01-01)

Leishmaniasis Visceral Infantil: Reporte de Caso y Revisión de Literatura1
by: Ibrahim Clós Mahmud, et al.
Published: (2014-04-01)

Canine visceral leishmaniasis in area with recent Leishmania transmission: prevalence, diagnosis, and molecular identification of the infecting species
by: Josiane Valadão Lopes, et al.
Published: (2020-09-01)

The kinetoplast in the diagnosis of visceral leishmaniasis
by: Henry W. Murray
Published: (2022-01-01)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
by: Claudia I. Brodskyn, et al.
Published: (2018-07-01)

Application of Liposome Technology in the Treatment of Leishmaniasis: Past, Present and Future
by: Amir Mellati, et al.
Published: (2023-12-01)

The Treatment Based on Ruxolitinib and Amphotericin B is Effective for Relapsed Leishmaniasis-Related Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
by: Cui T, et al.
Published: (2022-11-01)

Liposomal dual delivery systems in visceral leishmaniasis enhance the synergistic effects of combination therapy: A promise for the future
by: Raghunath Hazra, et al.
Published: (2024-01-01)

Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico
by: Pei-Hsuan Tsai, et al.
Published: (2021-12-01)

A Challenging Case of Visceral Leishmaniasis
by: Antonio Giovanni Solimando, et al.
Published: (2022-06-01)

Visceral Leishmaniasis Treatment, Italy
by: Luigi Gradoni, et al.
Published: (2003-12-01)

Visceral Leishmaniasis, Northern Somalia, 2013–2019
by: Mikko K. Aalto, et al.
Published: (2020-01-01)

Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants
by: Tarik Mouttaki, et al.
Published: (2018-04-01)

Acute liver failure due to visceral leishmaniasis in Barcelona: a case report
by: Iratxe Martinez de Narvajas, et al.
Published: (2019-10-01)

Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods
by: Juliana Quero Reimão, et al.
Published: (2020-10-01)

Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease
by: Bruno Mendes Roatt, et al.
Published: (2014-06-01)

First autochthonous case of canine visceral leishmaniasis in Rondônia, Brazil, a region with no history of visceral leishmaniasis
by: Cristian José da Silva, et al.

Evaluation of parasitological examination, kDNA polymerase chain reaction and rK39-based immunochromatography for the diagnosis of visceral leishmaniasis in seropositive dogs from the screening-culling program in Brazil
by: Shara Regina-Silva, et al.
Published: (2014-08-01)

Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate
by: Gregorio Basile, et al.
Published: (2020-08-01)

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case
by: Maria Antonia Ferreira Gomes, et al.

Visceral Leishmaniasis in Bolivia: Current Status
by: Juan Sergio Mollinedo, et al.
Published: (2020-10-01)

Metabolomics analysis of visceral leishmaniasis based on urine of golden hamsters
by: Dongmei Yuan, et al.
Published: (2023-08-01)

Berberine-Loaded Liposomes for the Treatment of <i>Leishmania infantum</i>-Infected BALB/c Mice
by: Alba Calvo, et al.
Published: (2020-09-01)